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Abstract In order to elucidate energy balance in the skeletal 
muscle, we cloned cDNA of a homologue of uncoupling protein 
(UCP) from rat skeletal muscle. We also cloned rat UCP-2 
cDNA from rat brown adipose tissue (BAT). The UCP cloned 
from rat skeletal muscle showed 57% and 72% identity with rat 
UCP-1 and UCP-2. The mRNA was expressed abundantly in the 
skeletal muscle, moderately in the BAT, and slightly in the white 
adipose tissue (WAT) with a major band at 2.5 kb and a minor 
band at 2.8 kb, while the UCP-2 gene expression was widely 
detected in the whole body with substantial levels in the WAT 
and with slight levels in the skeletal muscle and BAT. The rat 
UCP cloned in the present study showed 86% identity with the 
recently cloned human UCP-3, which was also expressed 
abundantly in the skeletal muscle with a signal of 2.4 kb. 
Therefore, the rat UCP was considered to be rat UCP-3. In rats 
fed high-fat diet the UCP-3 gene expression was augmented 2-
fold in the skeletal muscle while UCP-2 mRNA levels were 
increased significantly (1.6-fold) in the epididymal WAT. 
Augmented expression of UCPs may provide defense against 
high-fat induced obesity and impairment of glucose metabolism. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The regulation of energy metabolism involves food intake 
and energy expenditure [1]. In contrast to recent significant 
advances in the understanding of central regulatory circuits of 
food intake [2], much less is known about the molecular basis 
of energy expenditure. A major component of energy expen-
diture is nonshivering thermogenesis [3]. Nonshivering ther-
mogenesis has been implicated in the regulation of body tem-
perature, body weight and metabolism. Mitochondrial 
proteins called uncoupling proteins (UCPs) induce nonshiver-
ing thermogenesis by creating a pathway that allows dissipa-
tion of the proton electrochemical gradient across the inner 
mitochondrial membrane [4]. UCP-1 is expressed exclusively 
in the brown adipose tissue (BAT) [5-7], an important site of 
energy expenditure in rodents. The significance of UCP-1 in 
adult humans, however, is questionable because of low 
amount of BAT. Therefore, the existence of other member 
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of UCPs in tissues other than BAT has been postulated. Re-
cently two groups reported the cloning of UCP-2 cDNA in 
mice and humans, which is expressed widely in the whole 
body [8,9]. However, UCP-2 mRNA levels were low in the 
skeletal muscle [8,9], which has been implicated in a substan-
tial portion of nonshivering thermogenesis [10-15]. Therefore, 
it is postulated that other member of UCP may exist in the 
skeletal muscle. In the present study, we isolated and se-
quenced cDNA of a homologue of UCP highly expressed in 
rat skeletal muscle. In addition, since the cloning of rat UCP-
2 cDNA has not been reported yet, in order to examine the 
possibility that our cloned UCP would be rat UCP-2, we 
isolated and sequenced rat UCP-2 cDNA. We compared our 
cloned UCP to the rat UCP-2 and the recently cloned human 
UCP-3 [16,17]. 
The pathophysiological significance of UCPs in tissues oth-
er than the BAT remains to be elucidated. Mice lacking in 
UCP-1 have been cold-sensitive but not obese [18]. Postulated 
up-regulation of UCPs other than UCP-1 may explain the 
prevention of obesity in mice lacking in UCP-1. The effects 
of uncoupling of electron transport and ATP synthesis have 
been investigated by the incubation of cultured muscle cells, 
L6 cells, and cultured adipocytes, 3T3-L1 cells with chemical 
uncouplers such as 2,4-dinitrophenol (DNP) [19,20]. The un-
coupling causes the increase of the rate of electron transport 
in the mitochondria to maintain the ratio of ATP:ADP, 
which leads to the increase of rate of glycolysis and fatty 
acid break down. Glucose uptake was also increased by chem-
ical uncouplers in L6 cells and 3T3-L1 cells. These findings 
suggest that UCP may regulate metabolism of carbohydrate 
and lipid as well as body corpulency. Recently the UCP-2 
gene expression has been reported to be increased in the 
WAT in response to high-fat feeding [8]. Rats fed high-fat 
diet are accompanied by obesity and impairment of glucose 
metabolism [21]. In the present study, in order to elucidate 
pathophysiological significance of our cloned UCP and UCP-
2 in obesity and impairment of glucose metabolism, we exam-
ined the expression of these genes in the skeletal muscle, BAT 
and WAT from rats fed high-fat diet. 
2. Materials and methods 
2.1. Isolation of cDNA of UCP expressed in rat skeletal muscle 
Based on the coding sequence of the mouse UCP-2 cDNA [8,9], 
sense and antisense primers (sense: 5'-TAC GAC TCT GTC AAA 
CAG TTC TAY AC-3'; antisense: 5'-ATA GGT GAC AAA CAT 
CAC TAC RTT CCA-3') were prepared. Reverse transcription-PCR 
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(RT-PCR) was performed using Superscript (Gibco, Grand Island, 
NY) and oligo (dT)-primers with 10 ug of total RNA from rat gastro-
cnemius muscle as described [22]. The PCR products were subcloned 
for sequencing. A 0.6 kb PCR product encoding protein which 
showed 69% and 54% identity with partial sequences of mouse 
UCP-2 and rat UCP-1, respectively, was obtained. The 5'-rapid am-
plification of cDNA ends (RACE) and 3'-RACE of the cDNA were 
performed using 1 ug of poly (A) RNA from rat gastrocnemius 
muscle, and gene-specific primers (5'-RACE: 5'-GCC AAG TCC 
CTT TCC ACA GTC CCC TGA C-3'; 3'-RACE: 5'-CTG TGG 
AAA GGG ACT TGG CCC AAC ATC-3') with Marathon cDNA 
Amplification Kit (Clontech Laboratories, Palo Alto, CA). PCR was 
carried out using LA-Taq Polymerase (Takara, Otsu, Japan) and the 
following conditions: 20 s at 94°C and 3 min at 68°C for 30 cycles. 
PCR products were sequenced after subcloning into the pGEMT Easy 
vector (Promega, Madison, WI). To exclude nucleotide misincorpora-
tions during PCR, products of more than two independent PCRs were 
sequenced. 
2.2. Isolation of rat UCP-2 cDNA 
Based on the noncoding sequence of mouse UCP-2 cDNA [8,9], 
sense and antisense primers (sense: 5'-TCT CCA ATT TCT CTC 
CAT CTT CTG G-3'; antisense: 5'-TCC AGG TCA GCA TGG 
AGA GCC-3') were prepared. RT-PCR of rat UCP-2 cDNA was 
performed using these primers and 1 ug of poly (A) RNA from the 
BAT as described above. PCR was carried out using LA-Taq Poly-
merase and the following conditions: 20 s at 94°C, 10 s at 55°C and 
1 min and 20 s at 68°C for 32 cycles. To exclude nucleotide misin-
corporations during PCR, products of more than two independent 
PCRs were sequenced. 
2.3. Tissue preparation, total RNA extraction and Northern blot 
analysis 
Twelve week-old male Sprague-Dawley (SD) rats were killed by 
decapitation after a blow to the head. Tissues were immediately re-
moved from rats, frozen in liquid nitrogen and stored at —80°C until 
use. Total RNA was extracted using Trizol reagent (Gibco) [23]. 
Northern blot analysis was performed as described previously [21]. 
The probe of the rat UCP cloned in the present study was a 0.6 kb 
fragment containing amino-acid residues #105-281. The rat UCP-2 
probe was a 1.0 kb fragment spanning the entire open reading frame. 
The rat UCP-1 probe was prepared by RT-PCR using primers (sense: 
5'-TAT TCA TTG GGC AGC CCA CAG AGG-3'; antisense: 5'-
ACA CAA ACA TGA TGA CGT TCC AGG-3') and 10 ug of total 
RNA [22]. The specific activities of these probes were all 1.7-1.9 X109 
cpm/ug DNA. 
For the study of tissue distribution of gene expression, Rat Multiple 
Tissue Northern Blots (#7764-1) containing 2 ug of poly (A) RNA 
per lane (Clontech Laboratories), and the filters containing 10 ug of 
total RNA from subcutaneous WAT, epididymal WAT, interscapular 
BAT and gastrocnemius muscle were used. The density of 18 S rRNA 
stained with ethidium bromide was used to monitor the amount of 
total RNA in each sample. 
2.4. High-fat diet experiment 
Eight week-old male SD rats were used. Rats were housed in a 
temperature-, humidity-, and light-controlled room with free access 
to water and food. These animals were fed standard diet (n=4), or 
high-fat diet (n-4) for 4 weeks as described below. The high-fat diet 
contained 7.5% carbohydrate (wheat flour and bran), 24.5% protein 
(mainly casein) and 60% fat (mainly lard), whereas the control diet 
was a standard rat chow containing 61% carbohydrate (wheat flour), 
27% protein (bran and corn) and 12% fat (corn oil) [24]. A 0.2 ml 
blood was sampled from the tail vein after overnight fasting, and the 
plasma glucose, total cholesterol, and insulin levels were measured. 
Plasma total cholesterol and triglyceride levels were measured using 
the blood sampled without fasting on the previous day of the sacrifice. 
Gastrocnemius muscle, interscapular BAT and epididymal WAT were 
sampled at the end of the experiment, and RNA extraction was per-
formed as described above. 
Filters containing 10 ug of total RNA from the gastrocnemius 
muscle, interscapular BAT and epididymal WAT were prepared. 
The density of 18 S rRNA stained with ethidium bromide was used 
to monitor the amount of total RNA in each sample. Northern blot 
hybridization was performed as described above. The mRNA levels of 
the rat UCP cloned in the present study and UCP-2 (arbitrary units) 
were expressed relative to those in the gastrocnemius muscle from 
control rats fed standard diet (the mRNA levels in 10 jug of total 
RNA of the gastrocnemius muscle from control rats fed standard 
diet were defined as 100 units). 
2.5. Statistical analysis 
Data were expressed as the mean±S.E.M. The statistical signifi-
cance of differences between groups was assessed by Student's un-
paired Mest. 
3. Results and discussion 
Using degenerate primers based on the coding sequence of 
the mouse UCP-2 cDNA, RT-PCR was performed with total 
RNA from rat gastrocnemius muscle. The PCR product en-
coding protein which showed 69% and 54% identity with par-
tial sequences of mouse UCP-2 and rat UCP-1, respectively, 
was isolated. Using 5'-RACE and 3'-RACE, cDNA contain-
ing the entire open reading frame was obtained. The protein 
encoded by the entire open reading frame of the cDNA 
showed 73% identity with mouse UCP-2. The relatively low 
identity with mouse UCP-2 suggests that the protein is a 
member of UCP but not rat UCP-2. 
The cloning of rat UCP-2 cDNA has not been reported yet. 
In order to further exclude the possibility that the rat UCP 
cloned in the present study would correspond to rat UCP-2, 
we cloned and sequenced rat UCP-2 cDNA using RT-PCR 
with primers of noncoding sequence of the mouse UCP-2 
cDNA. The rat UCP-2 cDNA encodes a 309 amino-acid pro-
tein showing 99%o and 95% identity with the mouse and hu-
man UCP-2, indicating that rat UCP-2 is highly homologous 
to mouse and human UCP-2. The rat UCP cloned in the 
present study showed 57% and 72% identity with rat UCP-1 
and rat UCP-2, respectively (Fig. 1). Therefore, the rat UCP is 
a member of UCPs but distinct from rat UCP-2. 
In order to further characterize the UCP cloned from rat 
skeletal muscle, the tissue distribution of the gene expression 
in rats was examined by Northern blot analyses. The cDNA 
probe hybridized two bands, a major band at 2.5 kb and a 
minor band at 2.8 kb in rat tissues (Fig. 2). The mRNA was 
expressed at the highest level in the skeletal muscle, and mod-
erately in the interscapular BAT. Only weak signals were de-
tected in the epididymal WAT and the heart. Slight signals 
were observed in the subcutaneous WAT and the spleen with 
longer exposure time for autoradiography (data not shown). 
The ratio of intensity of the major band to that of the minor 
band did not vary among the samples. These results demon-
strate that the rat UCP is a member of UCP family highly 
expressed in the skeletal muscle. 
During the preparation of this manuscript, recently two 
groups reported the cloning of human UCP-3 cDNA, and 
that human UCP-3 mRNA was detected abundantly in hu-
man skeletal muscle with a signal of 2.4 kb [16,17]. Human 
UCP-3 encodes a 312 amino-acid protein showing 86% iden-
tity with rat UCP cloned in the present study which consists 
of 308 amino acids. Although the numbers of amino acids of 
the rat UCP cloned in the present study and human UCP-3 
are different, the abundant gene expression of the rat UCP in 
the skeletal muscle with a major band at similar size to human 
UCP-3 mRNA indicates that the rat UCP corresponds to a 
rat counterpart of human UCP-3, namely, rat UCP-3. The rat 
UCP is called rat UCP-3 in the remaining part of the paper. 
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r U C P - 1 MVSSTTSEVQPTMGVKIFSAGVSACLADIITF PLDTAKVR1QIQGEGQA SSTIRTKGVLGTITTLAKTEGLPKLISGLPAGIQRQI 86 ** * ** ** ** ** ** ***************** * * ****** * *** ** ** ** *** 
rUCP-2 MVGFKATDVPPTATVKFLGAGTAACIADLITr PLDTAKVR1 QIQGESgGLARTAASAQTRGVLGTILTMVRTEGPRSLTNGLVAGLQRQM 90 
*** **** *********** *** **************** * * ******************** * ****** *** 
rUCP-3 MVGLQPSEVPPTTWKFLGAGTAACFADLLTFPLDTAKVR1QIQGENPGVQ SVQYRGVLGTILTMVRTEGPRSPYSGLVAGLHRQM 86 
**** ** **** *************** ***************** ** ******************* *** ****** *** 
hUCP-3 MVGLKPSDVPPTMAVKFLGAGTAACrADLVTF|PLDTAKVRIJQIQGENQAVQ-TARLVQYRGVLGTILTMVRTEGPCSPINGLVAGLQRQM 89 II 
rUCP-1 SFASLRIGLYDTVQEIFSSGRETPASLGSKISAGLMTGGVAVFIGQ PTEWKVRN O&QSKLHG—IKPRITGTINAYRVIATTESLSTLW 174 
**** ****** * * * * ** ** ** ** *** ***** *** ** * ** ** * **
 -p_, 
rUCP-2 SFASVRIGLYDSVKQFYTKGSE-HAGIGSRLLAGSTTGALAVAVAQPTDWKVRFDAQARAG GGRRYQSTVEAYKTIAREEGIRGLW 176 
**** ************* * * *** **** ** ************* * * * * * * ** ******* **** 
rUCP-3 SFASIRIGLYDSVKQFYTPKGTDHSSVAIRILAGCTTGAMAVTCAQ PTDWKVRF 2AMIRLG-TGGERKYRGTMDAYRTIAREEGVRGLW 175 
*************** ***** * ** **************************** * ** *** ******************* 
hUCP-3 SFASIRIGLYDSVKQVYTPKGADNSSLTTRILAGCTTGAMAVTCAQPTDWKVRFOASIHLGPSRSDRKYSGTMDAYRTIAREEGVRGLW 179 III 
rUCP-1 KGTTPNLMRNVIINCTELVTYDLMKGALVNHHILADDVPCHLLSALVAGFCTTLLAE PVDWKTRF INSLPGQYPSVPSCAMTMYTKEGP 264 
*** ** ** * ********** * * ** *** ** ****** ********** ** *** * ** ** **** 
rUCP-2 KGTSPNVARNAIVNCTELVTYDLIKDTLLKANLMTDDLPCHFTSAFGAGFCTTVIAE PVDWXTRS MNSALGQYHSAGHCALTMLRKEGP 266 
*** ** ******* * **** ** ** * ** **** ******** ** ************* * * * ** * * *** _. 
rUCP-3 KGTWPNITRNAIVNCAEMVTYDIIKEKLLDSHLFTDNFPCHFVSAFGAGFCATWAE PVDWKTRYMNAPPGRYRSPLHCMLRMVAQEGP 265 
*** *** ********* ***** ****** ** ********************************** *** * *** ** ******* 
hUCP-3 KGTLPNIMPJJAIVNCAEVVTYDILKEKLLDYHLLTDNrPCHrVSArGAGrCATVVASJPVDVVKTRYlMNSPPGQYFSPLDCMIKMVAQEGP 269 
IV 
rUCP-1 AAFFKGFAPSFLRLGSWNVIMFVCFEQLKKELMKSRQTVDCTT 
** *** *********** *** ***** ** 
rUCP-2 RAFYKGF14PSFLRLGSWNVVMFVTYEQLKRALMAAYESREAPF 
****************** ************* * ** ** 
rUCP-3 TAFYKGFMPSFLRLGSWNVMMFVTYEQLKRALMKVQVLRESPF 
******* *********** **************** ****** 
hUCP-3 TArYKGrTPSFLRLGSWNWMFVTYEQLKRALMKVQMLRESPF 
307 
309 
308 
312 
VI 
Fig. 1. Comparison of the amino-acid sequences of rat UCP-1, rat UCP-2 (GenBank Accession AB006613), rat UCP-3 (GenBank Accession 
AB006614) and human UCP-3 (UCP-3L). Rat UCP-3 was called the rat UCP cloned in the present study in the former part of the text where 
the establishment of the rat UCP as rat UCP-3 had not been done. The sequences were presented in single letter code. Potential membrane-
spanning domains were underlined and numbered in roman numerals. The potential purine nucleotide binding domain was underlined doubly. 
The three mitochondrial energy-transfer protein signatures were boxed. Identities between sequences were shown in asterisks. 
Rat UCP-3 cDNA contains a 5'-untranslated region of ap-
proximately 0.2 kb, a 3'-untranslated region of approximately 
1.4 kb and an open reading frame encoding a 308 amino-acid 
protein which has a molecular weight of approximately 34 
kD. Hydrophobicity profile of rat UCP-3 demonstrates that 
it contains six predicted membrane-spanning domains like 
other mitochondrial carriers (Fig. 1). Potential purine nucleo-
tide binding domain, which is implicated in the control of the 
coupling efficiency [25], was noted in amino-acid residues 
#263-271 (Fig. 1). Three mitochondrial energy-transfer pro-
tein signatures [26] were identified (Fig. 1). These observations 
suggest that rat UCP-3 cloned in the present study uncouples 
mitochondrial respiration. There have been reported to be two 
forms of UCP-3 cDNA in humans, UCP-3L and UCP-3S, 
which may be due to alternative splicing [16]. U C P - 3 L con-
tains six predicted membrane-spanning domains like UCP-1 
and UCP-2 while UCP-3s lacks the sixth membrane-spanning 
domain. In the 3'-RACE of the present study we cloned only 
rat UCP-3 corresponding to human U C P - 3 L - Northern blot 
analyses demonstrated that rat UCP-3 mRNA was detected as 
two bands (Fig. 2). It may be due to alternative polyadenyla-
tion. Alternatively, U C P - 3 L and UCP-3g may explain the two 
bands although human UCP-3L and UCP-3s was detected as 
a single band [16]. 
We compared the gene expression of UCP-3 with that of 
UCP-2 in rat tissues (Fig. 2). The UCP-2 cDNA probe hy-
bridized a 1.7 kb band. The UCP-2 gene expression was de-
tected widely in the whole body, especially abundantly in the 
lung and the spleen. UCP-2 mRNA was also observed in the 
heart, liver, brain, kidney, testis, WAT, BAT and skeletal 
muscle. In contrast to the UCP-3 gene expression, the UCP-
2 gene expression was expressed at substantial levels in the 
WAT and only at slight levels in the skeletal muscle and BAT. 
The Northern blot analyses of UCP-3 and UCP-2 (Fig. 2) 
were performed with the probes of approximately the same 
specific activities and the same exposure time for autoradiog-
raphy, while the probe for UCP-2 was approximately 1.7-fold 
longer than that for UCP-3. Although accurate comparison 
between mRNA levels of UCP-3 and UCP-2 is difficult, Fig. 2 
indicates that the most abundant UCP expressed in the skel-
etal muscle is UCP-3 in rats. 
The UCP-3 mRNA levels were rather higher in the BAT of 
rats and mice in previous reports [16,17] as compared with our 
present finding. That difference may be due to using human 
UCP-3 cDNA as a probe in the previous reports. Moreover, 
the UCP-2 mRNA levels in rat BAT in our present finding 
were almost the same as those in some previous report [9], but 
were lower than those in other previous reports [8,16,17]. That 
Fig. 2. Tissue distribution of the gene expression of rat UCP-3 and 
UCP-2 analysed by Northern blots. Rat UCP-3 was called the rat 
UCP cloned in the present study in the former part of the text 
where the establishment of the rat UCP as rat UCP-3 had not been 
done. Results of UCP-3 and UCP-2 mRNA levels were shown in 
upper and lower portions, respectively. Two ug of poly (A) RNA 
and 10 ug of total RNA were used in left and right panels, respec-
tively. Muscle, skeletal muscle; BAT, interscapular brown adipose 
tissue; WAT (sub), subcutaneous white adipose tissue; WAT (epi), 
epididymal WAT. 
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Fig. 3. Northern blot analyses of rat UCP-3 and UCP-2 mRNA in the gastrocnemius muscle, interscapular BAT and epididymal WAT from 
rats fed standard diet (S) and those fed high-fat diet (H). Total RNA (10 u,g/lane) was analysed. A: Representative blots. B: The rat UCP-3 
mRNA levels (n-4). C: The rat UCP-2 mRNA levels (n = 4). *.P<0.05 compared with rats fed standard diet. Muscle, gastrocnemius muscle; 
BAT, interscapular brown adipose tissue; WAT, epididymal white adipose tissue. 
variation may be explained by the difference of probes used. 
When we compared the UCP-2 mRNA levels in the skeletal 
muscle of rats and mice of our finding and other reports with 
those of humans in previous reports, the UCP-2 mRNA levels 
in some samples from human skeletal muscle were rather 
higher, while those in other samples were approximately the 
same levels [8,9,16,17]. In order to elucidate this discrepancy, 
further studies using more number of samples from human 
skeletal muscle are necessary since the number of the samples 
in the previous reports appeared very few. 
Next we focused on the pathophysiologic significance of 
UCP-3 in the skeletal muscles. Skeletal muscle is one of the 
major tissues responsible for glucose uptake. Bashan et al. and 
Tsakiridis et al. reported that glucose uptake was elevated in 
L6 muscle cells and 3T3-L1 adipocytes by treatment of chem-
ical uncouplers such as 2,4-DNP, and that synthesis and 
translocation of glucose transporters were augmented by the 
treatment of the chemical uncouplers [19,20]. Together with 
these findings, it is tempting to speculate that UCP-3 abun-
dantly expressed in the skeletal muscle may contribute to reg-
ulation of glucose uptake, and that the regulation of the UCP-
3 gene expression can affect glucose metabolism in the skeletal 
muscle. 
Recently Fleury et al. reported the up-regulation of the 
UCP-2 mRNA levels in the epididymal WAT in response to 
high-fat diet feeding [8]. We investigated the gene expression 
of UCP-3 in the gastrocnemius muscle, interscapular BAT 
and epididymal WAT from rats fed standard diet and those 
fed high-fat diet. Table 1 summarizes the brief profile of rats 
fed standard diet and those fed high-fat diet. Rats fed high-fat 
diet weighed 114% more than control rats fed standard diet, 
and developed hyperglycemia and hyperinsulinemia (Table 1). 
The weight of the epididymal WAT increased 2.7-fold as com-
pared with those from rats fed standard diet. The UCP-3 gene 
expression was augmented 2-fold in the gastrocnemius muscle 
from rats fed high-fat diet (P<0.05) (Fig. 3). The UCP-3 
mRNA levels remained unchanged in the interscapular 
BAT, and epididymal WAT. The ratio of intensity of the 
major band to that of the minor band did not change. The 
levels of the UCP-2 gene expression were augmented signifi-
cantly in the epididymal WAT (1.6-fold) (i><0.05), while no 
significant increase was observed in the gastrocnemius muscle 
and interscapular BAT (Fig. 3). The UCP-1 mRNA levels 
remained unaffected in the BAT (data not shown) as previ-
ously reported [27]. Thus, the UCP-3 gene expression was 
preferentially augmented in the skeletal muscle in response 
to high-fat feeding, while the UCP-2 mRNA levels were pref-
erentially increased in the WAT. Transgenic expression of 
UCP-1 in the WAT has been reported to reduce genetic obe-
sity in mice [28]. As discussed above, the modulation of oxi-
dative chain by chemical uncouplers increased glucose uptake, 
synthesis and translocation of glucose transporters [19,20]. It 
is tempting to speculate that the increased expression of the 
UCP-3 gene in the skeletal muscle and the UCP-2 gene in the 
WAT can provide defense against high-fat induced obesity 
and impairment of glucose metabolism. The mechanisms of 
up-regulation of the gene expression in response to high-fat 
diet require further investigation. 
It has been reported that mice lacking in UCP-1 were cold-
sensitive but not obese, and that the mRNA levels of UCP-2 
were up-regulated in the BAT [18]. Furthermore, mice lacking 
in dopamine p-hydroxylase, which showed decreased basal 
UCP-1 mRNA levels and unaffected UCP-2 mRNA levels 
as compared with those in heterozygous mice, did not become 
obese [29]. In these mice UCP-3 and UCP-2 may contribute to 
prevention of obesity by their augmented expression. 
In the present study, we cloned and sequenced cDNAs of 
rat UCP-3 and UCP-2. The present study also demonstrates 
that the rat UCP-3 gene expression was augmented preferen-
tially in the skeletal muscle from rats fed high-fat diet while 
the UCP-2 mRNA levels were increased in the epididymal 
WAT from these mice. The elucidation of the pathophysio-
Table 1 
Profiles of rats fed standard diet and those fed high-fat diet 
Standard diet High-fat diet 
Body weight (g) 
Glucose (mg/dl) 
Total cholesterol (mg/dl) 
Triglyceride (mg/dl) 
Insulin (uU/ml) 
Epididymal fat weight (g) 
Values are mean±S.E.M. (n = 4 
389 ±15 
96±3 
61 ± 3 
121 ±19 
6.3 ±1.0 
3.2 ±0.2 
). *P<0.05; **P<0.01 vs. standard diet. 
443 + 5* 
139 + 2** 
63 ±3 
238 ±61 
45.4 ±5.8** 
8.6 ±0.7** 
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logical significance of UCP-3 and UCP-2 awaits analyses us-
ing transgenic mice with knockout or overexpression of these 
genes. 
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